Literature DB >> 14560901

Nonoperative treatment of adult acquired flat foot with the Arizona brace.

Jeffrey F Augustin1, Sheldon S Lin, Wayne S Berberian, Jeffrey E Johnson.   

Abstract

Nonoperative treatment of posterior tibial tendon dysfunction can be successful with the Arizona AFO brace, particularly when treatment is initiated in the early stages of the disease. This mandates that the orthopedist has a high index of suspicion when evaluating patients to make an accurate diagnosis. Although there is a role for surgical management of acquired flat feet, a well-fitted, custom-molded leather and polypropylene orthosis can be effective at relieving symptoms and either obviating or delaying any surgical intervention. In today's climate of patient satisfaction directed health care, a less invasive treatment modality that relieves pain may prove to be more valuable than similar pain relief that is obtained after surgery. Questions regarding the long-term results of bracing remain unanswered. Future studies are needed to determine if disease progression and arthrosis occur despite symptomatic relief with a brace. Furthermore, age- and disease stage-matched control groups who are randomized to undergo surgery or bracing are necessary to compare these different treatment modalities. At this time, the Arizona AFO brace can be a useful weapon in the orthopedist's armamentarium for treating acquired flat foot deformity.

Entities:  

Mesh:

Year:  2003        PMID: 14560901     DOI: 10.1016/s1083-7515(03)00036-6

Source DB:  PubMed          Journal:  Foot Ankle Clin        ISSN: 1083-7515            Impact factor:   1.653


  15 in total

1.  Approach and treatment of the adult acquired flatfoot deformity.

Authors:  Ettore Vulcano; Jonathan T Deland; Scott J Ellis
Journal:  Curr Rev Musculoskelet Med       Date:  2013-12

Review 2.  Operative management options for symptomatic flexible adult acquired flatfoot deformity: a review.

Authors:  Htwe Zaw; James D F Calder
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-02       Impact factor: 4.342

Review 3.  Adult-acquired flatfoot deformity.

Authors:  Niall A Smyth; Amiethab A Aiyer; Jonathan R Kaplan; Clayton A Carmody; Anish R Kadakia
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-03-21

4.  Choosing among 3 ankle-foot orthoses for a patient with stage II posterior tibial tendon dysfunction.

Authors:  Christopher G Neville; Jeff R Houck
Journal:  J Orthop Sports Phys Ther       Date:  2009-11       Impact factor: 4.751

5.  Effect of ankle-foot orthotic devices on foot kinematics in Stage II posterior tibial tendon dysfunction.

Authors:  Christopher Neville; Frederick R Lemley
Journal:  Foot Ankle Int       Date:  2012-05       Impact factor: 2.827

6.  Tendoscopic debridement for stage I posterior tibial tendon dysfunction.

Authors:  Hung Tsan Chow; Kwok Bill Chan; Tun Hing Lui
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2005-06-11       Impact factor: 4.342

7.  An Ankle-Foot Orthosis With a Lateral Extension Reduces Forefoot Abduction in Subjects With Stage II Posterior Tibial Tendon Dysfunction.

Authors:  Christopher Neville; Mary Bucklin; Nathaniel Ordway; Frederick Lemley
Journal:  J Orthop Sports Phys Ther       Date:  2015-12-11       Impact factor: 4.751

8.  Ultrasound elasticity imaging for determining the mechanical properties of human posterior tibial tendon: a cadaveric study.

Authors:  Liang Gao; Justin S Yuan; Gregory J Heden; John A Szivek; Mihra S Taljanovic; L Daniel Latt; Russell S Witte
Journal:  IEEE Trans Biomed Eng       Date:  2015-04       Impact factor: 4.538

9.  Ankle and foot kinematics associated with stage II PTTD during stance.

Authors:  Jeff R Houck; Christopher G Neville; Josh Tome; Adolph S Flemister
Journal:  Foot Ankle Int       Date:  2009-06       Impact factor: 2.827

Review 10.  Reported selection criteria for adult acquired flatfoot deformity and posterior tibial tendon dysfunction: Are they one and the same? A systematic review.

Authors:  Megan H Ross; Michelle D Smith; Bill Vicenzino
Journal:  PLoS One       Date:  2017-12-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.